top of page

Publications & Science

1. Iversen E, Kallemose T, Hornum M, Bengaard AK, Nehlin JO, Rasmussen LJH, Sandholdt H, Tavenier J, Feldt-Rasmussen B, Andersen O, Eugen-Olsen J, Houlind MB (2022) Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease. Clin Kidney J. 15(8):1534-1541. doi: 10.1093/ckj/sfac048. PMID: 35892012.

2. ​Luo S, Vasbinder A, Du-Fay-de-Lavallaz JM, Gomez JMD, Suboc T, Anderson E, Tekumulla A, Shadid H, Berlin H, Pan M, Azam TU, Khaleel I, Padalia K, Meloche C, O'Hayer P, Catalan T, Blakely P, Launius C, Amadi KM, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos- Bourboulis EJ, Altintas I, Eugen-Olsen J, Williams KA, Volgman AS, Reiser J, Hayek SS; ISIC (International Study of Inflammation in COVID‐19) Group (2022). Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19. J Am Heart Assoc. 11(18):e025198. doi: 10.1161/JAHA.122.025198. PMID: 35924778.

3. Walls AB, Bengaard AK, Iversen E, Nguyen CN, Kallemose T, Juul-Larsen HG, Jawad BN, Hornum M, Andersen O, Eugen-Olsen J, Houlind MB (2021) Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department . Pharmaceuticals (Basel). 14(9):843. doi: 10.3390/ph14090843. PMID: 34577543.

4. Tavenier, J., Rasmussen, L.J.H., Andersen, A.L., Houlind, M.B., Langkilde, A., Andersen, O., Petersen, J. and Nehlin, J.O. (2021) Association of GDF15 with inflammation and physical function during aging and recovery after acute illness/hospitalization: a longitudinal study of older hospitalized patients and age-matched controls. J Gerontol A Biol Sci Med Sci. 76(6):964-974. doi: 10.1093/gerona/glab011. PMID: 33428715.

5. Tavenier, J., Andersen, O., Nehlin, J.O., Petersen, J. (2021) Longitudinal course of GDF15 levels before acute hospitalization and death in the general population. Geroscience. 43(4):1835-1849. doi: 10.1007/s11357-021-00359-5. PMID: 33763774.

6. Azam TU, Shadid HR, Blakely P, O'Hayer P, Berlin H, Pan M, Zhao P, Zhao L, Pennathur S, Pop-Busui R, Altintas I, Tingleff J, Stauning MA, Andersen O, Adami ME, Solomonidi N, Tsilika M, Tober-Lau P, Arnaoutoglou E, Keitel V, Tacke F, Chalkias A, Loosen SH, Giamarellos-Bourboulis EJ, Eugen-Olsen J, Reiser J, Hayek SS; International Study of Inflammation in COVID-19 (2020) Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI. J Am Soc Nephrol. 31(11):2725-2735. doi: 10.1681/ASN.2020060829. PMID: 32963090.

7. Iversen E, Houlind MB, Kallemose T, Rasmussen LJH, Hornum M, Feldt-Rasmussen B, Hayek SS, Andersen O, Eugen-Olsen J. (2020) Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients. Front Cell Dev Biol. 8:339. doi: 10.3389/fcell.2020.00339. eCollection.PMID: 32596235.

8. Juul-Larsen HG, Christensen LD, Bandholm T, Andersen O, Kallemose T, Jørgensen LM, Petersen J. Patterns of Multimorbidity and Differences in Healthcare Utilization and Complexity Among Acutely Hospitalized Medical Patients (≥65 Years) - A Latent Class Approach (2020). Clin Epidemiol. 12:245-259. doi: 10.2147/CLEP.S226586. PMID: 32184671

9. Juul-Larsen HG, Andersen O, Bandholm T, Bodilsen AC, Kallemose T, Jørgensen LM, Klausen HH, Gilkes H, Petersen J (2020). Differences in function and recovery profiles between patterns of multimorbidity among older medical patients the first year after an acute admission-An exploratory latent class analysis Arch Gerontol Geriatr. 86:103956. doi: 10.1016/j.archger.2019.103956. PMID: 31586786.

10. Iversen E, Houlind MB, Eugen-Olsen J (2020). Soluble Urokinase Receptor and Acute Kidney Injury. N Engl J Med. 382(22):2166-2167. doi: 10.1056/NEJMc2003613. PMID: 32459934.

11. Nehlin, J.O. and Andersen, O. and (2020) Molecular biomarkers of health. In: Explaining Health across sciences. Vol. 12. Springer, Healthy Ageing and Longevity, Vol. 12, pp. 243- 271.

12. Juul-Larsen HG, Christensen LD, Andersen O, Bandholm T, Kaae S, Petersen J. (2019) Development of the "chronic condition measurement guide": a new tool to measure chronic conditions in older people based on ICD-10 and ATC-codes. Eur Geriatr Med. 10(3):431-444. doi: 10.1007/s41999-019-00188-y. PMID: 34652799.

13. Persson F, Theilade S, Eugen-Olsen J, Rossing P, Parving HH Renin angiotensin system blockade reduces urinary levels of soluble urokinase plasminogen activator receptor (suPAR) in patients with type 2 diabetes (2016). J Diabetes Complications. 30(8):1440-1442. doi: 10.1016/j.jdiacomp.2016.07.003. PMID: 27475262.

14. T. Nirnberger1 , U.A. Eoff2 , D. Zuercher2 , T. Otter2 , M.A. Farrar3 and W.L. Crowley. 2Virtual Models for STAT5 and Notch-mediated Lineage Commitment in Lymphocytes. 

bottom of page